Seeking Alpha

SumZero's  Instablog

SumZero Fan.
  • BioSpecifics Technology Corp (BSTC) - Takeout Target ($52.94) Special Situations
     BioSpecifics Technology Corp (BSTC) - Target ($52.94) Special Situations Update   Expect BSTC takeout within months.

    AUXL - FDA Approval should be coming soon according to Zacks Analyst.


    BSTC will be taken out by AUXL. Auxilium received proceeds, net of offering expenses and underwriting discounts and commissions, of about $115.7 million. AUXL has around $70mm in cash on B/S and around $40mm credit facility.

    115.7 + 70 + 40 = 225.7 / 6.08mm shares of BSTC = $37 per share

    However, I believe AUXL will be forced to sweeten the offer price above $40, to the $45+ per share range.

    Note: The capital raising filing details beyond normal corporate G&A use, that the funds could be used for strategic or corporate acquisitions.
    Tags: BSTC.PK, AUXL, AUXL, BSTC, healthcare, M A, Xiaflex, Auxilium, Bisospecifics, arbitrage, special situations, take private, take-private, takeover, merger, merger and acquisition
    Oct 20 09:49 am | Link | Comment!
  • BioSpecifics Technology Corp (BSTC) - Target ($52.94) Special Situations Update
    AUXL - FDA Approval should be coming soon according to Zacks Analyst.

    Expect BSTC takeout within months.


    BSTC will be taken out by AUXL. Auxilium received proceeds, net of offering expenses and underwriting discounts and commissions, of about $115.7 million. AUXL has around $70mm in cash on B/S and around $40mm credit facility.

    115.7 + 70 + 40 = 225.7 / 6.08mm shares of BSTC = $37 per share

    However, I believe AUXL will be forced to sweeten the offer price above $40, to the $45+ per share range.

    Note: The capital raising filing details beyond normal corporate G&A use, that the funds could be used for strategic or corporate acquisitions.
    Tags: BSTC.PK, AUXL, AUXL, BSTC, healthcare, M A, Xiaflex, Auxilium, Bisospecifics, arbitrage, special situations, take private, take-private, takeover, merger, merger and acquisition
    Oct 15 10:38 am | Link | Comment!
  • BioSpecifics Technology Corp (BSTC) - Target ($52.94) Special Situations Update
    BioSpecifics Technology Corp (BSTC) - Target ($52.94) Special Situations Update
    October 14

    AUXL - FDA Approval should be coming soon according to Zacks Analyst.

    Expect BSTC takeout within months.


    BSTC will be taken out by AUXL. Auxilium received proceeds, net of offering expenses and underwriting discounts and commissions, of about $115.7 million. AUXL has around $70mm in cash on B/S and around $40mm credit facility.

    115.7 + 70 + 40 = 225.7 / 6.08mm shares of BSTC = $37 per share

    However, I believe AUXL will be forced to sweeten the offer price above $40, to the $45+ per share range.

    Note: The capital raising filing details beyond normal corporate G&A use, that the funds could be used for strategic or corporate acquisitions.
    Tags: AUXL, BSTC.PK, healthcare, M A, Xiaflex, Auxilium, Bisospecifics, arbitrage, special situations, take private, take-private, takeover, merger, merger and acquisition, Stocks, AUXL, BSTC.PK
    Oct 14 02:21 pm | Link | Comment!
Full index of posts »
Latest Followers

StockTalks

  • BioSpecifics Technology Corp (BSTC) - Arb play. Buy - Target $52.94 (71% upside of fair value) Buy BSTC and/or short AUXL
    Sep 23, 2009
More »
Posts by Ticker
AUXL, BSTC.PK

Latest Comments


Most Commented
  1. BioSpecifics Technology Corp (BSTC) - Target ($52.94) Special Situations Update (1 Comment)
  2. BioSpecifics Technology Corp (BSTC) - Target ($52.94) Special Situations Update (1 Comment)
Posts by Themes
Arb, arbitrage, Arbitrage, Auxilium, AUXL, Biospecifics, Bisospecifics, BSTC, BSTC.PK, Healthcare, healthcare, M A, Margin of Safety, Merger, merger, merger and acquisition, Special Situations, special situations, Stocks, Take Private, take private, take-private, takeover, Value, Value Investing, Xiaflex
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.